Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.

Ofman JJ, Gralnek IM, Udani J, Fennerty MB, Fass R.

Am J Med. 1999 Sep;107(3):219-27.

PMID:
10492314
[PubMed - indexed for MEDLINE]
2.

The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.

Ofman JJ, Dorn GH, Fennerty MB, Fass R.

Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. Review.

PMID:
11860409
[PubMed - indexed for MEDLINE]
Free Article
3.

Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.

Pandak WM, Arezo S, Everett S, Jesse R, DeCosta G, Crofts T, Gennings C, Siuta M, Zfass A.

J Clin Gastroenterol. 2002 Oct;35(4):307-14.

PMID:
12352293
[PubMed - indexed for MEDLINE]
4.

Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease.

Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, Fennerty MB.

Arch Intern Med. 1999 Oct 11;159(18):2161-8.

PMID:
10527293
[PubMed - indexed for MEDLINE]
5.

Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis.

Borzecki AM, Pedrosa MC, Prashker MJ.

Arch Intern Med. 2000 Mar 27;160(6):844-52.

PMID:
10737285
[PubMed - indexed for MEDLINE]
6.

Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.

Fass R, Fennerty MB, Johnson C, Camargo L, Sampliner RE.

J Clin Gastroenterol. 1999 Jan;28(1):36-9.

PMID:
9916663
[PubMed - indexed for MEDLINE]
7.

The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain.

Fass R, Fennerty MB, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE.

Gastroenterology. 1998 Jul;115(1):42-9.

PMID:
9649457
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of testing for gastroesophageal reflux disease: what do patients, physicians, and health insurers want?

Richter JE.

Am J Med. 1999 Sep;107(3):288-9. No abstract available.

PMID:
10492325
[PubMed - indexed for MEDLINE]
9.

The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.

Bautista J, Fullerton H, Briseno M, Cui H, Fass R.

Aliment Pharmacol Ther. 2004 May 15;19(10):1123-30.

PMID:
15142202
[PubMed - indexed for MEDLINE]
Free Article
10.

Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain.

Hewson EG, Sinclair JW, Dalton CB, Richter JE.

Am J Med. 1991 May;90(5):576-83.

PMID:
2029015
[PubMed - indexed for MEDLINE]
11.

Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.

Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD.

Aliment Pharmacol Ther. 1999 Jan;13(1):59-66.

PMID:
9892880
[PubMed - indexed for MEDLINE]
Free Article
12.

The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis.

Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB.

Aliment Pharmacol Ther. 2000 Apr;14(4):389-96.

PMID:
10759617
[PubMed - indexed for MEDLINE]
Free Article
13.

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.

Xia HH, Lai KC, Lam SK, Hu WH, Wong NY, Hui WM, Lau CP, Chen WH, Chan CK, Wong WM, Wong BC.

Aliment Pharmacol Ther. 2003 Feb;17(3):369-77.

PMID:
12562449
[PubMed - indexed for MEDLINE]
Free Article
14.

The cost-effectiveness of strategies to assess gastroesophageal reflux as an exacerbating factor in asthma.

O'Connor JF, Singer ME, Richter JE.

Am J Gastroenterol. 1999 Jun;94(6):1472-80.

PMID:
10364010
[PubMed - indexed for MEDLINE]
15.

Chest pain and gastroesophageal reflux disease.

Richter JE.

J Clin Gastroenterol. 2000 Apr;30(3 Suppl):S39-41.

PMID:
10777171
[PubMed - indexed for MEDLINE]
16.

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.

Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L.

Scand J Gastroenterol. 1998 Jan;33(1):15-20.

PMID:
9489902
[PubMed - indexed for MEDLINE]
17.

Noncardiac chest pain.

Botoman VA.

J Clin Gastroenterol. 2002 Jan;34(1):6-14. Review.

PMID:
11743240
[PubMed - indexed for MEDLINE]
18.

Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.

Wang WH, Huang JQ, Zheng GF, Wong WM, Lam SK, Karlberg J, Xia HH, Fass R, Wong BC.

Arch Intern Med. 2005 Jun 13;165(11):1222-8. Review.

PMID:
15956000
[PubMed - indexed for MEDLINE]
19.

Modern diagnosis of gastroesophageal reflux disease (GERD).

Galmiche JP, Scarpignato C.

Hepatogastroenterology. 1998 Sep-Oct;45(23):1308-15.

PMID:
9840059
[PubMed - indexed for MEDLINE]
20.

Approach to the patient with unexplained chest pain.

Katz PO.

Semin Gastrointest Dis. 2001 Jan;12(1):38-45. Review.

PMID:
11216468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk